Tenax Therapeutics (TENX) Competitors

Tenax Therapeutics (NASDAQ:TENX) and Anixa Biosciences (NASDAQ:ANIX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, community ranking, earnings, profitability, valuation, institutional ownership and risk.

Do institutionals and insiders hold more shares of TENX or ANIX?

1.7% of Tenax Therapeutics shares are held by institutional investors. Comparatively, 29.1% of Anixa Biosciences shares are held by institutional investors. 3.7% of Tenax Therapeutics shares are held by insiders. Comparatively, 25.3% of Anixa Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Is TENX or ANIX more profitable?

Tenax Therapeutics' return on equity of -46.00% beat Anixa Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tenax Therapeutics	N/A	-46.00%	-42.65%
Anixa Biosciences	N/A	-58.55%	-53.29%

Do analysts prefer TENX or ANIX?

Tenax Therapeutics presently has a consensus price target of $18.00, suggesting a potential upside of 224.32%. Anixa Biosciences has a consensus price target of $9.00, suggesting a potential upside of 215.79%. Given Tenax Therapeutics' higher possible upside, equities research analysts clearly believe Tenax Therapeutics is more favorable than Anixa Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenax Therapeutics	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25
Anixa Biosciences	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.25

Which has more volatility & risk, TENX or ANIX?

Tenax Therapeutics has a beta of 1.88, meaning that its stock price is 88% more volatile than the S&P 500. Comparatively, Anixa Biosciences has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500.

Does the MarketBeat Community prefer TENX or ANIX?

Tenax Therapeutics received 113 more outperform votes than Anixa Biosciences when rated by MarketBeat users. However, 76.19% of users gave Anixa Biosciences an outperform vote while only 54.92% of users gave Tenax Therapeutics an outperform vote.

Company	Underperform	Outperform
Tenax Therapeutics	Outperform Votes 145 54.92%	Underperform Votes 119 45.08%
Anixa Biosciences	Outperform Votes 32 76.19%	Underperform Votes 10 23.81%

Which has better earnings & valuation, TENX or ANIX?

Tenax Therapeutics has higher earnings, but lower revenue than Anixa Biosciences. Anixa Biosciences is trading at a lower price-to-earnings ratio than Tenax Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenax Therapeutics	N/A	N/A	-$7.71M	-$5.32	-1.04
Anixa Biosciences	$210K	436.96	-$12.55M	-$0.39	-7.31

Does the media prefer TENX or ANIX?

In the previous week, Anixa Biosciences had 3 more articles in the media than Tenax Therapeutics. MarketBeat recorded 6 mentions for Anixa Biosciences and 3 mentions for Tenax Therapeutics. Tenax Therapeutics' average media sentiment score of 0.93 beat Anixa Biosciences' score of 0.19 indicating that Tenax Therapeutics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tenax Therapeutics	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Anixa Biosciences	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Tenax Therapeutics beats Anixa Biosciences on 8 of the 14 factors compared between the two stocks.